A novel copper complex induces paraptosis in colon cancer cellsviathe activation of ER stress signalling

Journal of Cellular and Molecular Medicine

Volumn 16, Issue 1, 2012, Pages 142-151

  Gandin, Valentina ^a   Pellei, Maura ^b   Tisato, Francesco ^c   Porchia, Marina ^c   Santini, Carlo ^b   Marzano, Cristina ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF CAMERINO   (Italy)

^c CNR   (Italy)

Author keywords

Colon cancer; Copper(I) phosphine complexes; Endoplasmatic reticulum stress; Non apoptotic cell death; Proteasome

Indexed keywords

ANTINEOPLASTIC AGENT; COPPER;

ANIMAL; APOPTOSIS; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; COLON TUMOR; DRUG EFFECT; ENDOPLASMIC RETICULUM STRESS; HUMAN; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; ULTRASTRUCTURE;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; COLONIC NEOPLASMS; COPPER; ENDOPLASMIC RETICULUM STRESS; HUMANS; MOLECULAR STRUCTURE; SIGNAL TRANSDUCTION;

EID: 84855186145     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2011.01292.x     Document Type: Article

References (46)

1. Kartalou M, Essigmann JM. Mechanisms of resistance to cisplatin. Mutat Res. 2001; 478: 23-43.
2. Zhang CX, Lippard SJ. New metal complexes as potential therapeutics. Curr Opin Chem Biol. 2003; 7: 481-9.
3. Simon TM, Kunishima DH, Vibert GJ, et al Screening trial with the coordinated gold compound auranofin using mouse lymphocyte leukemia P388. Cancer Res. 1981; 41: 94-7.
4. Berners-Price SJ, Johnson RK, Mirabelli CK, et al Copper(I) complexes with bidentate tertiary phosphine ligands: solution chemistry and antitumor activity, Inorg Chem. 1987; 26: 3383-7.
5. Berners-Price SJ, Mirabelli CK, Johnson RK, et al In vivoantitumor activity andin vitrocytotoxic properties of bis [1, 2-bis(diphenylphosphino)ethane]gold(I) chloride. Cancer Res. 1986; 46: 5486-9.
6. Hoke GD, Macia RA, Meunier PC. In vivoandin vitrocardiotoxicity of a gold-containing antineoplastic drug candidate in the rabbit. Toxicol Appl Pharmacol. 1989; 100: 293-306.
7. Adwankar MK, Wycliff C, Samuelson AG. In vitrocytotoxic effect of new diphenylphosphinoethane-copper(I) complexes on human ovarian carcinoma cell lines. Indian J Exp Biol. 1997; 34: 810-4.
8. Sanghamitra NJ, Phatak P, Das S, et al Mechanism of cytotoxicity of copper(I) complexes of 1, 2-bis(diphenylphosphino)ethane. J Med Chem. 2005; 48: 977-85.
9. Marzano C, Gandin V, Pellei M, et al In vitroantitumor activity of the water soluble copper(I) complexes bearing the tris(hydroxymethyl)phosphine ligand. J Med Chem. 2008; 51: 798-808.
10. Marzano C, Pellei M, Colavito D, et al Synthesis, characterization andin vitroantitumor properties of tris(hydroxymethyl)phosphine copper(I) complexes containing the new bis(1, 2, 4-triazol-1-yl)acetate Ligand. J Med Chem. 2006; 49: 7317-24.
11. Tisato F, Marzano C, Porchia M, et al Copper in diseases and treatments, and copper-based anticancer strategies. Med Res Rev. 2010; 30: 708-49.
12. Marzano C, Pellei M, Tisato F, et al Copper complexes as anticancer agents. Anticancer Agents Med Chem. 2009; 9: 185-211.
13. Tardito S, Marchiò L. Copper compounds in anticancer strategies. Curr Med. Chem. 2009; 16: 1325-48.
14. Clarke PG. Developmental cell death: morphological diversity and multiple mechanisms. Anat Embryol. 1990; 181: 195-213.
15. Sperandio S, de Belle I, Bredesen DE. An alternative, nonapoptotic form of programmed cell death. Proc Natl Acad Sci USA. 2000; 97: 14376-81.
16. Tardito S, Isella C, Medico E, et al The thioxotriazole copper(II) complex A0 induces endoplasmic reticulum stress and paraptotic death in human cancer cells. J Biol Chem. 2009; 284: 24306-19.
17. Obeng EA, Carlson LM, Gutman DM, et al Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells. Blood. 2006; 107: 4907-16.
18. Ustundag Y, Bronk SF, Gores GJ. Proteasome inhibition-induces endoplasmic reticulum dysfunction and cell death of human cholangiocarcinoma cells. World J Gastroenterol. 2007; 13: 851-7.
19. Hindo SS, Frezza M, Tomco D, et al Metals in anticancer therapy: copper(II) complexes as inhibitors of the 20S proteasome. Eur J Med Chem 2009; 44: 4353-61.
20. Padhye S, Yang H, Jamadar A, et al New difluoro Knoevenagel condensates of curcumin, their Schiff bases and copper complexes as proteasome inhibitors and apoptosis inducers in cancer cells. Pharm Res. 2009; 26: 1874-80.
21. Ding WX, Ni HM, Yin XM. Absence of Bax switched MG132-induced apoptosis to non-apoptotic cell death that could be suppressed by transcriptional or translational inhibition. Apoptosis. 2007; 12: 2233-44.
22. Jemal A, Center MM, Desantis C, et al Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev. 2010; doi:
23. Huerta S, Goulet EJ, Livingston EH. Colon cancer and apoptosis. Am J Surg. 2006; 191: 517-26.
24. Gourdier I, Del Rio M, Crabbé L, et al Drug specific resistance to oxaliplatin is associated with apoptosis defect in a cellular model of colon carcinoma. FEBS Lett. 2001; 529: 232-6.
25. Raymond E, Faivre S, Chaney S, et al Cellular and molecular pharmacology of oxaliplatin. Mol Cancer Ther. 2002; 1: 227-35.
26. Rabik CA, Dolan ME. Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev. 2007; 33: 9-23.
27. Marzano C, Mazzega Sbovata S, Gandin V, et al A new class of antitumor trans-amine-amidine-Pt(II) cationic complexes: influence of chemical structure and solvent onin vitroandin vivotumour cell proliferation. J Med Chem. 2010; doi:
28. Marzano C, Gandin V, Folda A, et al Inhibition of thioredoxin reductase by auranofin induces apoptosis in CisPt-resistant human ovarian cancer cells. Free Radic Biol Med. 2007; 42: 872-81.
29. Caicci F, Zaniolo G, Burighel P, et al Differentiation of papillae and rostral sensory neurons in the larva of the ascidian Botryllus schlosseri (Tunicata). J Comp Neurol. 2010; 518: 547-66.
30. Gatti L, Perego P. Cellular resistance to oxaliplatin and drug accumulation defects. In: Bonetti A et al ., editors. Cancer drug discovery and development platinum and other heavy metal compounds in cancer chemotherapy. New York : Humana Press; 2009. p. 115-24.
31. Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol. 1980; 68: 251-300.
32. Green DR. Apoptotic pathways: ten minutes to dead. Cell. 2005; 121: 671-4.
33. Wang Y, Li X, Wang L, et al An alternative form of paraptosis-like cell death, triggered by TAJ/TROY and enhanced by PDCD5 overexpression. J Cell Sci. 2004; 117: 1525-32.
34. Arango D, Wilson AJ, Shim Q. Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells. Br J Cancer. 2004; 91: 1931-46.
35. Zamzami N, Larochette N, Kroemer G. Mitochondrial permeability transition in apoptosis and necrosis. Cell Death Diff. 2005; 12: 1478-80.
36. Jo WS, Jeong MH, Jin YH, et al Loss of mitochondrial membrane potential and caspase activation enhance apoptosis in irradiated K562 cells treated with herbimycin A. Int J Radiat Biol. 2005; 81: 531-43.
37. Pourahmad J, Ross S, O'Brien PJ. Lysosomal involvement in hepatocyte cytotoxicity induced by Cu(21) but not Cd(21). Free Radic Biol Med. 2001; 30: 89-97.
38. Cvek B, Milacic V, Taraba J, et al Ni(II), Cu(II), and Zn(II) diethyldithiocarbamate complexes show various activities against the proteasome in breast cancer cells. J Med Chem. 2008; 51: 6256-8.
39. Schröder M, Kaufman RJ. The mammalian unfolded protein response. Annu Rev Biochem. 2005; 74: 739-89.
40. Blobel G, Dobberstein B. Transfer of proteins across membranes. I. Presence of proteolytically processed and unprocessed nascent immunoglobulin light chains on membrane-bound ribosomes of murine myeloma. J Cell Biol. 1975; 67: 835-51.
41. Dikic I, Johansen T, Kirkin V. Selective autophagy in cancer development and therapy. Cancer Res. 2010; 70: 3431-4.
42. Bröker LE, Kruyt FA, Giaccone G. Cell death independent of caspases: a review. Clin Cancer Res. 2005; 11: 3155-62.
43. Yagi S, Oda-Sato E, Uehara I, et al 5-Aza-2'-deoxycytidine restores proapoptotic function of p53 in cancer cells resistant to p53-induced apoptosis. Cancer Invest. 2008; 26: 680-8.
44. Liou JY, Aleksic N, Chen SF, et al Mitochondrial localization of cyclooxygenase-2 and calcium-independent phospholipase A2 in human cancer cells: implication in apoptosis resistance. Exp Cell Res. 2005; 306: 75-84.
45. Linder S, Shoshan MC. Lysosomes and endoplasmic reticulum: targets for improved, selective anticancer therapy. Drug Resist Updat. 2005; 8: 199-204.
46. Kisselev A, Callard A, Goldberg AL. Importance of the different proteolytic sites of the proteasome and the efficacy of inhibitors varies with the protein substrate. J Biol Chem. 2006; 281: 8582-90.